
Heart Health
Ubiquinol for Hearth Health
Ubiquinol supports cardiovascular health. The heart is one of the most energy intensive organs in the body, needing energy to continually pump. Ubiquinol is a key component required for cellular ATP energy production, the body’s primary fuel.
This fuel is used for three basic yet critical heart functions:
Contraction – to keep the heart pumping consistently Relaxation – to allow the heart to rest between beats
Molecular Synthesis – to maintain the heart’s structure by building important cellular components
Ubiquinol is a powerful lipid-soluble antioxidant, reducing free radical damage to the body’s cells, supporting overall health and wellbeing.
Ubiquinol helps in the maintenance of healthy blood lipids
Ubiuquinol acts as an antioxidant and helps support healthy cholesterol and blood vessels.
The Australian Heart Foundation reports that 33 percent of Australians have high total cholesterol8 (levels higher than 5.5 mmol/L) – quite a significant number.
Australia has the third highest use of cholesterol-lowering medications in the developed world.1
Statin drugs are the most common class of these medications. They work by inhibiting the body’s production of cholesterol, but in doing so, also deplete natural levels of CoQ10 and other essential vitamins and nutrients.
Ubiquinol supplementation helps to maintain healthy blood levels in the body when taking certain medications.4, 5
- OECD (2015), Health at a Glance 2015: OECD Indicators, OECD Publishing, Paris. http://dx.doi.org/10.1787/health_glance-2015-en
- Passi S, Stancato A, Aleo E, Dmitrieva A, Littarru GP. Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors. 2003;18(1-4):113-24.
- Ghirlanda, et al., Evidence of plasma CoQ10-lowering effect of HMG-COA reductase inhibitors: a double-blind, placebo-controlled study, Journal of Clinical Pharmacology. 1993 Mar; 33(3):226-229.
- Harper CR, Jacobson TA: The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol, 2007; 18: 401–8
- Wyman M, Leonard M, Morledge T: Coenzyme Q10: a therapy for hypertension and statin-induced mylgia? Cleve Clin J Med, 2010; 77: 435–42
- Marcoff L, Thompson PD: The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol, 2007; 49: 2231–37
- Skarlovnik A, Janic M, Lunder M, Turk M, Sabovic M. Coenzyme Q10 Supplementation Decreases Statin-Relted Mild-to-Moderate Muscle Symptoms: A Randomized Clinical Study. Med Sci Monit, 2014; 20:2183-2188.
- Zlatohlavek, L, et al. The effect of coenzyme Q10 in statin myopathy. Neuroendocrinol Letters, 2012; 33: 98-101
- National Heart Foundation of Australia. 2012. High cholesterol statistics. [ONLINE] Available at: https://www.heartfoundation.org.au/about-us/what-we-do/heart-disease-in-australia/high-cholesterol-statistics. [Accessed 15 July 2017].
- Black, P.H et al., 2002. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research, [Online]. Volume 52, Issue 1, 1-23. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11801260 [Accessed 14 July 2017].
- Schmelzer, C., Niklowitz, P., Okun, J. G., Haas, D., Menke, T. and Döring, F. (2011), Ubiquinol-induced gene expression signatures are translated into altered parameters of erythropoiesis and reduced low density lipoprotein cholesterol levels in humans. IUBMB Life, 63: 42–48.
- Thomas, S.R., 1996. Cosupplementation With Coenzyme Q Prevents the Prooxidant Effect of α-Tocopherol and Increases the Resistance of LDL to Transition Metal–Dependent Oxidation Initiation. Arteriosclerosis, Thrombosis, and Vascular Biology, [Online]. Volume 16, Issue 5, 687-696. Available at: http://atvb.ahajournals.org/content/16/5/687.long [Accessed 15 July 2017].
- St-Pierre, A.C. et al., 2005. Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Que´bec Cardiovascular Study. Arteriosclerosis, Thrombosis, and Vascular Biology, [Online]. Volume 25, Issue 3, 553-559. Available at: http://atvb.ahajournals.org/content/25/3/553.long [Accessed 15 July 2017].





















